Journal articles on the topic 'B. E. Robuck, Inc'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'B. E. Robuck, Inc.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Bartolome, Amelita, Anna Almazan, Salina Abusali, Stanley Tam, Eric Lee, Amogh Changavi, Wendy Trinh, et al. "1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool." Open Forum Infectious Diseases 5, suppl_1 (November 2018): S326. http://dx.doi.org/10.1093/ofid/ofy210.924.
Full textGomperts, Edward D., Shashikant Apte, Utpal Chaudhuri, Joseph M. John, Vijay Ramanan, Ri Liesner, Amy D. Shapiro, Bonnie J. Mills, and Martin Lee. "IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B." Blood 120, no. 21 (November 16, 2012): 2225. http://dx.doi.org/10.1182/blood.v120.21.2225.2225.
Full textKarasiewicz, Kathy, Shuyang He, Mary Ng, Kristina Tess, Weifang Ling, Gunnar F. Kaufmann, Jerome B. Zeldis, Henry Ji, Robert Hariri, and Xiaokui Zhang. "Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell Malignancies." Blood 134, Supplement_1 (November 13, 2019): 3222. http://dx.doi.org/10.1182/blood-2019-130782.
Full textCoyne-Beasley, Tamera, Joseph Bocchini, Alejandro Cane, Cindy Burman, Maria J. Tort, and Jessica Presa. "01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S124—S125. http://dx.doi.org/10.1093/ofid/ofab466.204.
Full textLasater, Elisabeth A., An D. Do, Luciana Burton, Yijin Li, Erin Williams, Jason Oeh, Luciana Molinero, et al. "Resistance of Natural Killer and T Cells to Venetoclax Allows for Combination Treatment with Cancer Immunotherapy Agents." Blood 132, Supplement 1 (November 29, 2018): 1118. http://dx.doi.org/10.1182/blood-2018-99-116405.
Full textHe, Jie, Jose A. Bufill, Michelle K. Nahas, Kai Wang, Lauren E. Young, Kristina M. Knapp, Kristina W. Brennan, et al. "Clinical Utility of Comprehensive Profiling of Genomic Alterations in Hematologic Malignancies." Blood 124, no. 21 (December 6, 2014): 1072. http://dx.doi.org/10.1182/blood.v124.21.1072.1072.
Full textGe, Jianning, Chunhui Yang, Jing Sun, Jiao Chen, Shuyi Qiu, Wenjie Yin, Lianjun Shen, Martina Sersch, Wei Cao, and Xinxin Wang. "Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies." Blood 138, Supplement 1 (November 5, 2021): 1722. http://dx.doi.org/10.1182/blood-2021-148500.
Full textLilley, Graham, Alden Ladd, Daniel Cossette, Laura Viggiano, Gregory Hopkins, John W. Evans, Mingli Li, et al. "Characterization of Lentiviral Vector Derived Anti-Bcma CAR T Cells Reveals Key Parameters for Robust Manufacturing of Cell-Based Gene Therapies for Multiple Myeloma." Blood 126, no. 23 (December 3, 2015): 3243. http://dx.doi.org/10.1182/blood.v126.23.3243.3243.
Full textTran, Thai Hong, Krupa Scott, Shyun-Shyun Lee, Reshma Singh, Shawn Cogan, Jennifer Bordeaux, Hummel Jennifer, et al. "Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials." Blood 126, no. 23 (December 3, 2015): 2659. http://dx.doi.org/10.1182/blood.v126.23.2659.2659.
Full textTotman, Jennifer, Dorothy Brach, Vinny Motwani, Selene Howe, Emily Deutschman, John Lampe, Thomas V. Riera, et al. "Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma." Blood 138, Supplement 1 (November 5, 2021): 1142. http://dx.doi.org/10.1182/blood-2021-151147.
Full textSchomer, Nathan Thomas, Laurent Boissel, Karen Jiang, Hans Klingemann, John H. Lee, and Patrick Soon-Shiong. "Providing a Homing Receptor for CAR Engineered NK Cells - Improving Cellular Immunotherapy for B-Cell Lymphoma." Blood 132, Supplement 1 (November 29, 2018): 4547. http://dx.doi.org/10.1182/blood-2018-99-116890.
Full textChang, Kai-Hsin, Minerva Sanchez, Jack Heath, Edouard deDreuzy, Scott Haskett, Abigail Vogelaar, Kiran Gogi, et al. "Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation Model." Blood 132, Supplement 1 (November 29, 2018): 409. http://dx.doi.org/10.1182/blood-2018-99-114780.
Full textCampbell, Veronica, Ryan Thompson, Vivian Villegas, Jennifer Proctor, Karen McGovern, Jeffery L. Kutok, and Howard M. Stern. "The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines." Blood 122, no. 21 (November 15, 2013): 1832. http://dx.doi.org/10.1182/blood.v122.21.1832.1832.
Full textToudjarska, Ivanka, Zuhua Cai, Tim Racie, Julia Hettinger, Stuart Milstein, Brian R. Bettencourt, Dinah WY Sah, David Bumcrot, John Maraganore, and Akshay Vaishnaw. "RNAi-Mediated Inhibition of Activated Protein C- A New Approach for Hemophilia Treatment." Blood 118, no. 21 (November 18, 2011): 1204. http://dx.doi.org/10.1182/blood.v118.21.1204.1204.
Full textStorhoff, James, Brett Wallden, Rita M. Braziel, Catherine Thieblemont, Tressa Hood, Harini Ravi, Shannon Dennis, et al. "Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples." Blood 126, no. 23 (December 3, 2015): 1481. http://dx.doi.org/10.1182/blood.v126.23.1481.1481.
Full textCoiffier, Bertrand, Juan-Manuel Sancho, Wojciech Jurczak, Jin Seok Kim, Raj V. Nagarkar, Edvard Zhavrid, Jose Angel Hernandez Rivas, et al. "Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)." Blood 128, no. 22 (December 2, 2016): 1807. http://dx.doi.org/10.1182/blood.v128.22.1807.1807.
Full textGanesan, Harish, Vipul Kumar, Sujata M. Bhavnani, David Melnick, and Christopher M. Rubino. "1105. Population Pharmacokinetic Analyses for Tebipenem After the Administration of Tebipenem Pivoxil Hydrobromide." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S644—S645. http://dx.doi.org/10.1093/ofid/ofab466.1299.
Full textMerrill, J. T., J. Guthridge, D. Zack, P. Foster, B. Burington, L. Tran, M. Smith, and J. A. James. "SAT0187 DISCRIMINATION OF SYSTEMIC LUPUS (SLE) PATIENTS WITH CLINICAL RESPONSE TO OBEXELIMAB (XMAB®5871) BASED ON A PATTERN OF IMMUNOLOGIC MARKERS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1035–36. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2972.
Full textDias, Lizalynn, Venkata Thodima, Geetu Mendiratta, Guttapalli Asha, Camille Gonzalez, Jocelyn C. Maragulia, Andrew D. Zelenetz, Julie Teruya Feldstein, Raju S. K. Chaganti, and Jane Houldsworth. "Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis." Blood 122, no. 21 (November 15, 2013): 4259. http://dx.doi.org/10.1182/blood.v122.21.4259.4259.
Full textHsieh, Y. T., C. Hubeau, V. Massa, W. LI, S. Frei, B. Capraro, A. Umana, et al. "OP0316 EMERGING BEST-IN-CLASS IL-2 VARIANT HIGHLIGHTS TREG-DIRECTED THERAPY FOR AUTOIMMUNE DISEASE." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 195.1–195. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1999.
Full textHarrington, Deirdre M., Sarahjane Belton, Tara Coppinger, Muireann Cullen, Alan Donnelly, Kieran Dowd, Teresa Keating, et al. "Results from Ireland’s 2014 Report Card on Physical Activity in Children and Youth." Journal of Physical Activity and Health 11, s1 (January 2014): S63—S68. http://dx.doi.org/10.1123/jpah.2014-0166.
Full textRiley, Brigit E., Jeff Boonsripisal, Alicia Goodwin, Dominique Cartier, Eudean Garces, Kate Nesbitt, Courtney Dwyer, et al. "Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy." Blood 128, no. 22 (December 2, 2016): 1173. http://dx.doi.org/10.1182/blood.v128.22.1173.1173.
Full textDias, Lizalynn, Venkata Thodima, Asha Guttapalli, Geetu Mendiratta, Sergei I. Syrbu, and Jane Houldsworth. "Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets." Blood 124, no. 21 (December 6, 2014): 2993. http://dx.doi.org/10.1182/blood.v124.21.2993.2993.
Full textAnguela, Xavier M., Rajiv Sharma, Yannick Doyon, Sunnie Y. Wong, David E. Paschon, Hojun Li, Virginia Haurigot, et al. "In Vivo Genome Editing of Liver Albumin for Therapeutic Gene Expression: Rescue of Hemophilic Mice Via Integration of Factor 9." Blood 120, no. 21 (November 16, 2012): 751. http://dx.doi.org/10.1182/blood.v120.21.751.751.
Full textTimmerman, John M., Kristopher K. Steward, Reiko E. Yamada, Patricia A. Young, Dena M. Minning, Raj K. Sachdev, Michael J. Gresser, Sanjay D. Khare, and Sherie L. Morrison. "Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas." Blood 126, no. 23 (December 3, 2015): 2762. http://dx.doi.org/10.1182/blood.v126.23.2762.2762.
Full textChekmasova, Alena A., Holly M. Horton, Tracy E. Garrett, John W. Evans, Johanna Griecci, Amanda Hamel, Howard J. Latimer, et al. "A Novel and Highly Potent CAR T Cell Drug Product for Treatment of BCMA-Expressing Hematological Malignances." Blood 126, no. 23 (December 3, 2015): 3094. http://dx.doi.org/10.1182/blood.v126.23.3094.3094.
Full textYounes, Anas, Connie Lee Batlevi, Jonathon B. Cohen, Sven de Vos, Daniel J. Landsburg, Zaw Win Myint, Krish Patel, et al. "A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma." Blood 134, Supplement_1 (November 13, 2019): 4104. http://dx.doi.org/10.1182/blood-2019-128857.
Full textBjordahl, Ryan, Raedun Clarke, Svetlana Gaidarova, Brian Groff, Paul Rogers, Stacey Moreno, Ramzey Abujarour, et al. "Off-the-Shelf Natural Killer Cell Immunotherapy for Enhanced Antibody Directed Cellular Cytotoxicity." Blood 128, no. 22 (December 2, 2016): 3363. http://dx.doi.org/10.1182/blood.v128.22.3363.3363.
Full textSommer, Cesar, Hsin-Yuan Cheng, Yik Andy Yeung, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton, et al. "Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia." Blood 134, Supplement_1 (November 13, 2019): 3921. http://dx.doi.org/10.1182/blood-2019-129025.
Full textRichon, Victoria M., Christopher J. Sneeringer, Margaret Porter Scott, Kevin W. Kuntz, Sarah K. Knutson, Roy M. Pollock, and Robert A. Copeland. "Lymphoma-Associated Mutations of EZH2 Result In a Change-of-Function." Blood 116, no. 21 (November 19, 2010): 707. http://dx.doi.org/10.1182/blood.v116.21.707.707.
Full textHuard, Justin, Laurie Tatalick, Carl Walkey, and Ryan Swanson. "NL-201, a De Novo Agonist of IL-2 and IL-15 Receptors, Demonstrates Synergistic Antitumor Activity with Anti-PD-1 Checkpoint Inhibitor Therapy in a Preclinical Non-Hodgkin Lymphoma Model." Blood 138, Supplement 1 (November 5, 2021): 4560. http://dx.doi.org/10.1182/blood-2021-148885.
Full textGyurkocza, Boglarka, Rajneesh Nath, Patrick J. Stiff, Edward Agura, Mark Litzow, Ben Tomlinson, Hannah K. Choe, et al. "Re-Induction and Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial." Blood 134, Supplement_1 (November 13, 2019): 5642. http://dx.doi.org/10.1182/blood-2019-122776.
Full textStorms, Robert W., Congxiao Liu, Elisabeth T. Tracy, Tracy Gentry, Andrew Balber, and Joanne Kurtzberg. "ALDHbr Hematopoietic Progenitors Promote Short-Term Engraftment in Experimental Models for Cord Blood Transplantation." Blood 114, no. 22 (November 20, 2009): 2433. http://dx.doi.org/10.1182/blood.v114.22.2433.2433.
Full textRosen, David B., James A. Cordeiro, David M. Soper, Ying-Wen Huang, Donna E. Hogge, Roland B. Walter, Alessandra Cesano, and Wendy J. Fantl. "Distinct Signaling Profiles of Gemtuzumab Ozogamicin Responsiveness and Refractoriness in Acute Myeloid Leukemia." Blood 114, no. 22 (November 20, 2009): 2745. http://dx.doi.org/10.1182/blood.v114.22.2745.2745.
Full textHowell, Stephen B., Hongying Zhang, and William G. Rice. "A Phase 1a/b Dose Escalation Study of Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS." Blood 134, Supplement_1 (November 13, 2019): 5148. http://dx.doi.org/10.1182/blood-2019-129685.
Full textSteen, Chloe B., Bogdan A. Luca, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, Brian Sworder, Farshad Farshidfar, Kiarash Shamardani, et al. "An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma." Blood 134, Supplement_1 (November 13, 2019): 655. http://dx.doi.org/10.1182/blood-2019-129461.
Full textStapleton, Ann, Aurelio Silvestroni, Pacita Roberts, Marsha Cox, Hillary Hayden, Mitchell Brittnacher, Samuel Miller, and Thomas Hooton. "126. Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo-Controlled (DBPC) Phase 2b Trial to Prevent Recurrent UTI (rUTI)." Open Forum Infectious Diseases 5, suppl_1 (November 2018): S8. http://dx.doi.org/10.1093/ofid/ofy209.016.
Full textSmolen, J. S., F. Behrens, S. Liu Leage, C. Sapin, I. De La Torre, G. Meszaros, G. Schett, et al. "AB0841 TARGET OUTCOMES IN PsA: SIMULTANEOUS ACHIEVEMENT of ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1726.2–1727. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2884.
Full textFang, Riguo, Yingchi Zhang, Pengfei Yuan, Huihui Yang, Lingling Yu, Yongjian Zhang, Jia Shi, et al. "Highly Efficient Gene Editing of Human Hematopoietic Stem Cells to Treat X-Linked Sideroblastic Anemia." Blood 136, Supplement 1 (November 5, 2020): 1. http://dx.doi.org/10.1182/blood-2020-140208.
Full textLawrence, Jody, Nicholas Kitchin, Annaliesa S. Anderson, Michael W. Pride, Kathrin U. Jansen, William C. Gruber, Yahong Peng, Kevin Yi, Charles Knirsch, and Chris Webber. "12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S29. http://dx.doi.org/10.1093/ofid/ofaa439.057.
Full textLoveday, Kenneth, Doriana Froim, Anna Pisania, Alissa Fernald, Mathew Spaits, R. Scott Pearsall, Ravi Kumar, and Kathryn W. Underwood. "ACE-536, a Novel GDF-Trap, Increases Hemoglobin, Hematocrit, and Red Blood Cell Levels in Rats and Monkeys." Blood 114, no. 22 (November 20, 2009): 3603. http://dx.doi.org/10.1182/blood.v114.22.3603.3603.
Full textSrinivasan, Surabhi, Nguyen Tan, Hsin-Yuan Cheng, Yi Zhang, Silvia Tacheva-Grigorova, Tom Van Blarcom, Cesar Sommer, Duy Nguyen, Barbra Sasu, and Siler Panowski. "Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML." Blood 136, Supplement 1 (November 5, 2020): 23. http://dx.doi.org/10.1182/blood-2020-142161.
Full textPeterson, James, Daniel Drazan, Hanna Czajka, Jason Maguire, Jean-Louis Pregaldien, Ilkka Seppa, Roger Maansson, et al. "6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S25—S26. http://dx.doi.org/10.1093/ofid/ofaa439.051.
Full textSmith, Pascal, Evelyn Teh, Ken Chisholm, Susanne Penny, Devanand Pinto, Kelcey Patterson, Brennan Dirk, et al. "Proteomic analysis of plasma exosomes as biomarkers of response to MVP-S based immunotherapy." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 66.09. http://dx.doi.org/10.4049/jimmunol.208.supp.66.09.
Full textCichocki, Frank, Ryan Bjordahl, Svetlana Gaidarova, Sajid Mahmood, Paul Rogers, Moyar Q. Ge, Dan S. Kaufman, Sarah Cooley, Bahram Valamehr, and Jeffrey S. Miller. "iPSC-Derived NK Cells and Anti-PD-1 Antibody Synergize to Enhance T Cell Cytokine and Cytolytic Responses Against Multiple Tumors." Blood 132, Supplement 1 (November 29, 2018): 730. http://dx.doi.org/10.1182/blood-2018-99-114893.
Full textZinzani, Pier Luigi, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, Dolores Caballero, et al. "Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study." Blood 136, Supplement 1 (November 5, 2020): 42–43. http://dx.doi.org/10.1182/blood-2020-137080.
Full textNowakowski, Grzegorz, Annalisa Chiappella, Fangxin Hong, Randy D. Gascoyne, David W. Scott, William R. Macon, Rebecca L. King, et al. "Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies." Blood 134, Supplement_1 (November 13, 2019): 4092. http://dx.doi.org/10.1182/blood-2019-123083.
Full textMartinowitz, Uri, Amy D. Shapiro, Doris V. Quon, Miguel Antonio Escobar, Christine L. Kempton, Peter Collins, Pratima Chowdary, et al. "Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis." Blood 118, no. 21 (November 18, 2011): 2267. http://dx.doi.org/10.1182/blood.v118.21.2267.2267.
Full textKirsch, Ilan, Zijun Yidan Xu-Monette, Thomas Snyder, and Ken H. Young. "Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification." Blood 124, no. 21 (December 6, 2014): 1669. http://dx.doi.org/10.1182/blood.v124.21.1669.1669.
Full textMinson, Katherine A., Madeline G. Huey, Amanda A. Hill, Irene Perez, Xiaodong Wang, Stephen Frye, H. Shelton Earp, Deborah DeRyckere, and Douglas K. Graham. "Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Leukemia." Blood 128, no. 22 (December 2, 2016): 2819. http://dx.doi.org/10.1182/blood.v128.22.2819.2819.
Full text